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Objective: To evaluate the test-retest and concurrent validity of the L-test in a group of participants 
with mild to moderate Parkinson’s disease.  The L-test is an extended version of the Timed up and 
Go test, incorporating a longer walking distance and turns in two directions.    
Design: Cross-sectional 
Setting: Community  
Participants: 16 participants (13 male), mean age 75 (± 6.7) mean duration since diagnosis 7.1 years 
(± 2.8). Disease severity was mild to moderate on the Hoehn and Yahr scale (mean 2.1; mode 2; 
range 1-3).  14 participants (12 male) completed the study.  
Interventions: Not applicable 
Main outcome measures: A Bland and Altman plot examined the agreement between first and 
second testing occasion of the L-test.  Intra-class correlation coefficients (ICC) assessed the test-
retest reliability.  Concurrent validity was established by correlating the L-test with the Timed up and 
Go test (TUG).  The Minimal Detectable Change with 95% confidence interval (MDC95) was 
calculated to determine the true change not due to chance.  
Results: The L-test showed excellent test-retest reliability on the Bland & Altman plot and the ICC.  
There was a high degree of agreement between measurements taken on day 1 and 2.  The L-test 
correlated strongly with the Timed up and Go test on both measurement days with r = 0.97 (p< 
0.001) and r = 0.96 (p< 0.001).  The MDC95 was 5.31 seconds.   
Conclusions: The L-test is a reliable and valid outcome measurement for the assessment of walking 
ability in participants with mild to moderate Parkinson’s disease. 













This study has established for the first time the reliability and validity of the L-test of functional 
mobility in participants with Parkinson’s disease 
The study also calculated the Minimum Detectable Change (MDC95) of the L-test as well as the Timed 
up and Go test.  The MDC95 for the L-test was 5.31 sec and 4.35 sec for the Timed up and Go test 
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Introduction 
Parkinson’s disease (PD) is a progressive degenerative neurological conditions which leads to 
significant motor and non-motor symptoms(1,2). Two of the major signs of PD, hypokinesia and 
rigidity in particular can have a negative effect on gait, balance and mobility due to the decline in 
rhythmic, co-ordinated movements(3). Impairments of gait relate closely to activity limitations in 
this patient group(4).  The assessment and monitoring of gait function depends on the availability of 
valid and reliable outcome measurements. In particular, simple tools which are easy to use can yield 
the greatest benefit in research and clinical practice.  A number of tools have been developed that 
include timed tests of walking speed or walking endurance.  However, not all of these tests have 
been validated for use in people with PD.  The 10-m walk test has shown good repeatability in 
people with PD(5), however, this test only assesses simple straight walking and therefore has 
limitations in people who have specific difficulties in turning.  Similarly, the 6-minute walk test has 
shown excellent repeatability (5), but taking the recommended minimum of two consecutive 
assessments may be a problem for some people with PD with limited walking endurance.     The 
timed up and go (TUG) test is frequently used in the assessment of gait in a number of conditions, 













used in studies involving people with PD (9–11).  It is highly recommended as a tool to assess 
mobility and falls risk due to its simplicity and ease of completion (12). Longer TUG times are 
generally associated with decreased mobility and increased number of falls, but the standard TUG 
may not be sophisticated enough to differentiate sufficiently between individuals at the various 
stages of the disease progression in PD (13).  Reliability of the TUG has been found to be ‘good’ to 
‘excellent’ in people with PD (14–16), but the TUG only assesses turning in a preferred direction 
where unilateral impairments may be masked by the opportunity to turn in a preferred direction (9). 
Therefore, despite good reliability and validity the TUG has limitations in PD which may currently 
only be overcome by adding complex and potentially prohibitively expensive instrumentation.   The L 
test is a modification of the TUG which extends the walking distance from 6 to 20 meters and also 
requires participants to make turns in both a clockwise and anticlockwise direction.  It therefore may 
have the potential to overcome limited sensitivity and ceiling effects.  The L test was initially devised 
for people following lower limb amputation (17) and has since been evaluated  in people following 
stroke (18) and hospitalised older people (9).  In all three studies the L test has shown good reliability 
and also correlated well with the TUG.  The aim of this study was to assess the L test in a group of 




In total, 16 participants with PD were recruited through the local Parkinson’s UK group and the 
Parkinson’s UK Research Support network (13 males).  Their mean age (Standard Deviation) was 75 
years (± 6.7) and their mean duration from diagnosis with PD was 7.1 years (± 2.8). Disease severity 
was mild to moderate on the Hoehn and Yahr scale (19) (mean 2.1; mode 2; range 1-3).  Exclusion 
criteria were any significant co-morbidities affecting gait and balance, inability to walk 20 meters 













the second testing session and therefore 14 participants (12 male) completed the study.  The study 
was approved by the University Ethics committee and all people participated with informed written 
consent in accordance with the Declaration of Helsinki. 
Outcome measurements 
Timed up and go test  
The TUG is a commonly used measure of mobility.  The test comprises of a rise from a standard 
chair, a 3m walk, 180 degree turn around a cone or line before returning to the chair to sit down. 
The recorded time beginning on the word “go” and ending when the participant’s back touches the 
back of the chair. We used a chair without armrests for all tests.   
 
L test of functional mobility 
The L-Test is an extended version of the TUG, designed to assess advanced functional ambulation 
with further details provided elsewhere (18).  The time is recorded as the participant stands up from 
the chair, walks 3m to a cone, turns 90 degrees to the right, continues walking 7m to the next cone, 
turns left 180 degrees around the cone, then returns to the chair along the same path. The recorded 
time beginning on the word “go” and ending when the participant’s back touches the back of the 




Participants completed two timed trials of both outcome measurements, with a one-minute rest 
between trials and a two-minute rest between measurements. This was performed on two 













the trials were completed at approximately the same time of day. Participants completed the TUG 
and L-Test in a randomised order, which was kept consistent between the two occasions. 
Participants were instructed to walk at their comfortable walking speed, with or without any of their 
usual walking aids. Prior to participation, the participants received a standardised demonstration 
and explanation of both outcome measurements. For participant safety, chairs were placed in close 
proximity to the testing area.  In addition, one of the researchers walked in close proximity to the 
participant without providing any encouragement or trying to set the walking pace. The mean times 
of both trials were used for data analysis. 
 
Statistical analysis 
Data was analysed using the Statistical Package for the Social Sciences (SPSS) (IBM Corp. SPSS 
Statistics for Windows, Version 22.0. Armonk, NY, USA).   Data was tested for normality using 
Shapiro-Wilk test and this indicated that the data was not normally distributed.  Therefore, we 
applied log transformation prior to data analysis. Test-retest reliability was determined using 
intraclass correlation coefficients (ICC) with a confidence interval (CI) of 95%. Reliability was 
considered poor if the ICC <0.40, moderate to good if 0.41-0.74 and excellent if >0.75 (20,21). In 
addition, we then used the ICC results to calculate the Minimal Detectable Change (MDC at 95% 
confidence interval – MDC95) of both the TUG and the L  test using the following formula(22): 
 MDC95 = 1.96 x SEM x √2 ;  
The Standard Error of Measurement (SEM) was calculated in the following way:  
SEM = SD x √[1 − 𝑟]; (SD is the Standard Deviation of the baseline test and r is the ICC reliability 
coefficient).  
Agreement of the L-test measurements between testing occasion 1 and 2 were also evaluated using 













Concurrent validity was examined by determining the correlation between the TUG and the L-Test 
using Pearson’s correlation coefficients (r). Correlations were considered negligible if between 0 and 
0.20, weak if 0.21 - 0.40, moderate if 0.41 - 0.60, strong if 0.61 - 0.80 and very strong if 0.81 - 1.00 
(24). A power calculation showed that 7 participants would be required to demonstrate a power β = 
0.97 with a correlation of r = 0.96 and p = 0.05 (25).  
 
Results 
The mean (Standard Deviation - SD) time taken to complete the TUG on occasions 1 and 2 were 
15.33 sec (± 5.6) and 12.48 sec (± 6.5) respectively.  The mean (SD) time taken to complete the L-test 
on occasions 1 and 2 were 35.46 sec (± 11.1) and 29.66 sec (± 15.3) respectively.  
Test – retest reliability and Minimally Detectable Change  
Figure 2 shows the Bland and Altman plot for the test –retest agreement between the L-test scores 
on day 1 and day 2. All data points are within two standard deviations and do not indicate a 
systematic bias.  The mean difference between the two measurement days was 2.12 seconds.  This 
also represents the bias or the difference between the mean difference between the two results and 
zero difference.   
The ICC for the TUG was 0.92 (95% CI: 0.75- 0.98) and the ICC for the L-test was 0.97 (95% CI: 0.86-
0.99).  Therefore, the test – retest reliability for both tests was determined to be excellent.  The 
MDC95 for the TUG was 4.35 sec and for the L-test was 5.31 sec.   
Concurrent validity    
A positive significant correlation was found between the TUG and the L-test on both testing 
occasions.  Pearson’s correlation coefficients were r = 0.97 (p< 0.001) and r = 0.96 (p< 0.001) for 













strong.   Figures 3 and 4 show the relationships between the TUG and the L-test on testing occasions 
1 and 2 respectively. 
 
Discussion 
Our study aimed to evaluate the reliability and concurrent validity of the L-test of functional mobility 
in a group of participants with PD.  This is the first study to evaluate the L-test in this patient group.  
The ICC reliability coefficient for the TUG in our study  was 0.95 (95% CI: 0.75- 0.98) and this is 
regarded as ‘excellent’ according to published criteria (20,21).  Our ICC results for the TUG agree 
with the findings in other studies, which have also shown excellent reliability evaluations in 
participants with PD (5,14,26,27).  Our Bland and Altman plot of agreement suggests a high degree 
of agreement of the measurement scores between the two measurement occasions. The Bland and 
Altman plot does not show any systematic  difference over the range of walking speeds. In addition,  
calculated the ICC from the results of two measurement occasions one week apart and at a similar 
time of day.  The results for the test-retest ICC for the L-test in our study was 0.97 (95% CI: 0.86-
0.99) which also suggests excellent reliability.  This suggests that the L-test should be reliable 
irrespective of walking speed (23).  We also calculated the ‘Minimal Detectable Change’ (MDC95), 
and this was 5.31 sec.  The MDC is defined as the ‘minimal amount of change that is not likely to be 
due to chance’ (22).  For clinical practice, any improvements in walking speed following an 
intervention programme and measured by the L-test therefore need to be above 5.31 seconds, to be 
deemed clinically significant.  We also calculated the MDC95 for the TUG, which was 4.35 sec.  We are 
not aware of any previous MDC95 calculations for the TUG in this patient population, so future 
studies using the TUG may need to consider that true improvements in walking speed may need to 
be above 4.35 sec for this walking test.   
Our study demonstrated high construct validity of the  L-test; we used the well-established TUG test 













populations and widely used in clinical practice (6–11).  Other studies have similarly evaluated the 
construct validity of the L-test by testing the correlation with the TUG; these studies have also 
shown high correlations in stroke survivors (r = 0.89) (18), participants with lower limb amputations 
(r = 0.93) (17) and in an elderly population in hospital (r = 0.96) (9).  Our correlation coefficients of r 
= 0.96 and r = 0.97 for testing occasions 1 and 2 respectively are therefore very much in line with 
these findings in other patient populations. 
Our evaluation shows excellent reliability and validity of the L-test in this patient population.  
However, we are unable to demonstrate superiority or inferiority in comparison to the TUG.  The 
need for a larger testing area may limited the use to the L-test is some settings, but the added length 
and turns may be of interest in certain assessments.      
    
 
Limitations  
Our participants were mostly classified as Hoehn & Yahr stages 1 and 2 which corresponds to mild to 
moderate PD (19).  This is consistent with the level of disease progression that is observed within 
ambulatory, community dwelling people with PD (16); however, we are unable to comment on the 
suitability of this test in participants with PD and more severe walking limitations . For safety reasons 
a researcher walked in close proximity of all participants in all trials.  Whilst every effort was made 
that this should not influence the self-selected walking speed of the participant we cannot exclude 
this as a possibility. In addition, all trials were conducted in environments were potential distractions 
could not be excluded.  Whilst this had the potential of influencing the results it may also be 
considered as relating more closely to a realistic measurement environment in a real clinical 













However, we did not systematically record this, so therefore cannot comment which of these tests 
may trigger freezing more often. 
   
 
CONCLUSION: 
We conclude that the L-test of functional mobility is a reliable and valid test in people with mild to 
moderate PD.  The L-test provides an assessment of walking over a longer walking distance and 
involves turning in two directions, when compared to the TUG.  For the assessment of changes in 
walking ability a minimum change of 5.31 seconds is needed to demonstrate an actual change in 
performance in this patient group.  
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Figure 4: Relationship between TUG and L-test on day 2 
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